Sartorius Aktiengesellschaft confirmed consolidated financial guidance for the year 2022. Consolidated sales revenue is expected to increase by about 15% to 19%, with non-organic growth from acquisitions projected to contribute about 2% points.
Market Closed -
Other stock markets
|
After market 03:59:59 pm | |||
292.9 EUR | +1.17% | 293 | +0.03% |
May. 13 | Sartorius Partners With Sanofi for Biomanufacturing Platform | MT |
Apr. 30 | SARTORIUS : Target cut by -6.1% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.09% | 19.25B | |
-39.00% | 2.96B | |
+22.02% | 1.96B | |
-0.62% | 1.69B | |
+33.51% | 1.27B | |
-16.17% | 982M | |
-22.01% | 913M | |
+5.38% | 801M | |
-23.80% | 630M | |
+8.96% | 506M |
- Stock Market
- Equities
- SRT3 Stock
- News Sartorius AG
- Sartorius Aktiengesellschaft Confirms Consolidated Financial Guidance for the Year 2022